Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: Controlled study [1] (multiple letters)

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 466-467

  Krause, G ^a   Kroeger, A ^a   Soto, J ^a   Berman, J ^a  

^a Bureau of Epidemiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN;

DRUG EFFECT; HEALING; HUMAN; LETTER; OINTMENT; PRIORITY JOURNAL; SKIN DEFECT; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE;

EID: 0032777693     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520249     Document Type: Letter

References (0)